1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington: American Psychiatric Association; 2013.
2. Savard J, Ivers H, Villa J, Caplette-Gingras A, Morin CM. Natural course of insomnia comorbid with cancer: an 18-month longitudinal study. J Clin Oncol 2011;29:3580-6.
3. Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, et al. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-community clinical oncology program. J Clin Oncol 2010;28:292-8.
4. Park B, Youn S, Hann C-WC, Yi K, Lee S, Lee JS, et al. Prevalence of insomnia among patients with the ten most common cancers in South Korea: health insurance review and assessment service-national patient sample. Sleep Med Res 2016;7:48-54.
5. Zhou ES, Recklitis CJ. Insomnia in adult survivors of childhood cancer: a report from project REACH. Support Care Cancer 2014;22:3061-9.
6. Zhou ES, Manley PE, Marcus KJ, Recklitis CJ. Medical and psychosocial correlates of insomnia symptoms in adult survivors of pediatric brain tumors. J Pediatr Psychol 2016;41:623-30.
8. Savard J, Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 2001;19:895-908.
9. Walsh JK, Üstün TB. Prevalence and health consequences of insomnia. Sleep 1999;22:S427-36.
11. Taylor DJ, Lichstein KL, Durrence HH. Insomnia as a health risk factor. Behav Sleep Med 2003;1:227-47.
12. Fleming L, Gillespie S, Espie CA. The development and impact of insomnia on cancer survivors: a qualitative analysis. Psychooncology 2010;19:991-6.
14. Redeker NS, Lev EL, Ruggiero J. Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract 2000;14:275-90 ; discussion 291-8.
15. Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am 1987;10:541-53.
16. Lowery AE. Sleep and cancer. In Holland JC, Breitbart WS, Butow PN, Jacobsen PB, Loscalzo MJ, McCorkle R (eds.), Psycho-Oncology. 3rd ed. New York: Oxford University Press; 2015. p. 231.
17. van’t Spijker A, Trijsburg RW, Duivenvoorden HJ. Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med 1997;59:280-93.
18. Savard J, Simard S, Blanchet J, Ivers H, Morin CM. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep 2001;24:583-90.
19. Savard J, Hervouet S, Ivers H. Prostate cancer treatments and their side effects are associated with increased insomnia. Psychooncology 2013;22:1381-8.
20. Enderlin CA, Coleman EA, Cole C, Richards KC, Hutchins LF, Sherman AC. Sleep across chemotherapy treatment: a growing concern for women older than 50 with breast cancer. Oncol Nurs Forum 2010;37:461-A3.
21. Van Onselen C, Paul SM, Lee K, Dunn L, Aouizerat BE, West C, et al. Trajectories of sleep disturbance and daytime sleepiness in women before and after surgery for breast cancer. J Pain Symptom Manage 2013;45:244-60.
22. Costa AR, Fontes F, Pereira S, Gonçalves M, Azevedo A, Lunet N. Impact of breast cancer treatments on sleep disturbances-a systematic review. Breast 2014;23:697-709.
24. Ancoli-Israel S. Recognition and treatment of sleep disturbances in cancer. J Clin Oncol 2009;27:5864-6.
25. Woodward SC. Cognitive-behavioral therapy for insomnia in patients with cancer. Clin J Oncol Nurs 2011;15:E42-52.
26. Graci G. Pathogenesis and management of cancer-related insomnia. J Support Oncol 2005;3:349-59.
27. Fergus KD, Gray RE. Relationship vulnerabilities during breast cancer: patient and partner perspectives. Psychooncology 2009;18:1311-22.
28. Holmberg SK, Scott LL, Alexy W, Fife BL. Relationship issues of women with breast cancer. Cancer Nurs 2001;24:53-60.
29. Walsh JK. Pharmacologic management of insomnia. J Clin Psychiatry 2004;65 Suppl 16:41-5.
30. Tariq SH, Pulisetty S. Pharmacotherapy for insomnia. Clin Geriatr Med 2008;24:93-105 ; vii.
32. Lemmo W. Potential interactions of prescription and over-the-counter medications having antioxidant capabilities with radiation and chemotherapy. Int J Cancer 2015;137:2525-33.
33. Jaeger H, Morrow GR, Carpenter PJ, Brescia F. A survey of psychotropic drug utilization by patients with advanced neoplastic disease. Gen Hosp Psychiatry 1985;7:353-60.
35. Casault L, Savard J, Ivers H, Savard MH, Simard S. Utilization of hypnotic medication in the context of cancer: predictors and frequency of use. Support Care Cancer 2012;20:1203-10.
36. National Institutes of Health. National Institutes of Health State of the science conference statement on manifestations and management of chronic insomnia in adults. June 13-15, 2005; Sleep; 2005;28:1049-57.
37. Wilson SJ, Nutt DJ, Alford C, Argyropoulos SV, Baldwin DS, Bateson AN, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol 2010;24:1577-601.
38. Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD; Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2016;165:125-33.
39. Morgenthaler T, Kramer M, Alessi C, Friedman L, Boehlecke B, Brown T, et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report. Sleep 2006;29:1415-9.
40. Zhou ES, Partridge AH, Syrjala KL, Michaud AL, Recklitis CJ. Evaluation and treatment of insomnia in adult cancer survivorship programs. J Cancer Surviv 2017;11:74-9.
41. Smith MT, Smith LJ, Nowakowski S, Perlis ML. Primary insomnia: diagnostic issues, treatment, and future directions. In Perlis ML, Lich-stein KL (eds.), Treating sleep disorders: principles and practice of behavioral sleep medicine. 1st ed. Hoboken: John Wiley & Sons, Inc; 2003. pp. 214-61.
43. Savard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part II: Immunologic effects. J Clin Oncol 2005;23:6097-106.
44. Espie CA, Fleming L, Cassidy J, Samuel L, Taylor LM, White CA, et al. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol 2008;26:4651-8.
45. Matthews EE, Schmiege SJ, Cook PF, Berger AM, Aloia MS. Adherence to cognitive behavioral therapy for insomnia (CBTI) among women following primary breast cancer treatment: a pilot study. Behav Sleep Med 2012;10:217-29.
46. Garland SN, Carlson LE, Stephens AJ, Antle MC, Samuels C, Campbell TS. Mindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, noninferiority trial. J Clin Oncol 2014;32:449-57.
47. Garland SN, Roscoe JA, Heckler CE, Barilla H, Gehrman P, Findley JC, et al. Effects of armodafinil and cognitive behavior therapy for insomnia on sleep continuity and daytime sleepiness in cancer survivors. Sleep Med 2016;20:18-24.
49. Garland SN, Johnson JA, Savard J, Gehrman P, Perlis M, Carlson L, et al. Sleeping well with cancer: a systematic review of cognitive behavioral therapy for insomnia in cancer patients. Neuropsychiatr Dis Treat 2014;10:1113-24.
50. Johnson JA, Rash JA, Campbell TS, Savard J, Gehrman PR, Perlis M, et al. A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Rev 2016;27:20-8.
51. Savard J, Villa J, Simard S, Ivers H, Morin CM. Feasibility of a self-help treatment for insomnia comorbid with cancer. Psychooncology 2011;20:1013-9.
52. Savard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects. J Clin Oncol 2005;23:6083-96.
54. Savard J, Simard S, Giguère I, Ivers H, Morin CM, Maunsell E, et al. Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: psychological and immunological effects. Palliat Support Care 2006;4:219-37.
56. Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed. Sleep 1987;10:45-56.
58. Mock V, Abernathy A, Atkinson A, Barsevick A, Berger A, Cella D. NCCN Clinical Practice Guidelines in OncologyTM. In: Cancer-related fatigue. Washington: National Comprehensive Cancer Network; 2015.
59. Cella D, Davis K, Breitbart W, Curt G; Fatigue Coalition. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 2001;19:3385-91.
60. Lichstein KL. Sleep compression treatment of an insomnoid. Behavior Therapy 1988;19:625-32.
61. Berger AM, Kuhn BR, Farr LA, Lynch JC, Agrawal S, Chamberlain J, et al. Behavioral therapy intervention trial to improve sleep quality and cancer-related fatigue. Psychooncology 2009;18:634-46.
62. Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull 2008;134:700-41.
63. Bootzin RR. Stimulus control treatment for insomnia. In: American psychological association. APA 80th Annual Convention; Honolulu: American Psychological Association. 1972. 1973.
64. Bootzin RR, Epstein D, Wood JM. Stimulus control instructions. In Hauri PJ (ed.), Case studies in insomnia. Boston: Springer; 1991. pp. 19-28.
65. Puder R, Lacks P, Bertelson AD, Storandt M. Short-term stimulus control treatment of insomnia in older adults. Behavior Therapy 1983;14:424-9.
67. Beck AT. Cognitive therapy of depression. 2nd ed. New York: Guilford Press; 1979.
68. Beck A, Emery G, Greenberg R. Anxiety disorders and phobias: a cognitive perspective. New York: Basic Books; 2005.
70. Harvey KJ, Espie CA. Development and preliminary validation of the Glasgow Content of Thoughts Inventory (GCTI): a new measure for the assessment of pre-sleep cognitive activity. Br J Clin Psychol 2004;43:409-20.
71. Chung S, Youn S, Choi B. Assessment of cancer-related dysfunctional beliefs about sleep for evaluating sleep disturbance in cancer patients. Sleep Med Res; 2017 Nov 3 [Epub ahead of print].
https://doi.org/10.17241/smr.2017.00073..
73. Lewy AJ. The dim light melatonin onset, melatonin assays and biological rhythm research in humans. Biol Signals Recept 1999;8:79-83.
77. Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol 2004;5:617-25.
78. Dettenborn L, James GD, Valdimarsdottir HB, Montgomery GH, Bovbjerg DH. Breast cancer-specific intrusions are associated with increased cortisol responses to daily life stressors in healthy women without personal or family histories of breast cancer. J Behav Med 2006;29:477-85.
79. Hauri P. The sleep disorders (Current concepts). 2nd ed. Kalamazoo: Upjohn; 1982. pp. 2-16.
80. Stepanski EJ, Wyatt JK. Use of sleep hygiene in the treatment of insomnia. Sleep Med Rev 2003;7:215-25.
81. Irish LA, Kline CE, Gunn HE, Buysse DJ, Hall MH. The role of sleep hygiene in promoting public health: A review of empirical evidence. Sleep Med Rev 2015;22:23-36.
82. Mastin DF, Bryson J, Corwyn R. Assessment of sleep hygiene using the Sleep Hygiene Index. J Behav Med 2006;29:223-7.
83. Simeit R, Deck R, Conta-Marx B. Sleep management training for cancer patients with insomnia. Support Care Cancer 2004;12:176-83.
84. Zupanec S, Jones H, McRae L, Papaconstantinou E, Weston J, Stremler R. A Sleep hygiene and relaxation intervention for children with acute lymphoblastic leukemia: a pilot randomized controlled trial. Cancer Nurs 2017;40:488-96.
86. Youn S, Hann C-WC, Park B, Lee S, Kim C, Yi K, et al. The sleeping pill prescription rate for inpatients at a general hospital. Sleep Medicine Research 2016;7:33-8.
87. Haynes PL, Bootzin RR. Insomnia treatments: moving from efficacy to effectiveness. J Clin Psychol 2010;66:1131-6.
88. Borkovec TD, Fowles DC. Controlled investigation of the effects of progressive and hypnotic relaxation on insomnia. J Abnorm Psychol 1973;82:153-8.
89. Nicassio P, Bootzin R. A comparison of progressive relaxation and autogenic training as treatments for insomnia. J Abnorm Psychol 1974;83:253-60.
90. Kahn M, Baker BL, Weiss JM. Treatment of insomnia by relaxation training. J Abnorm Psychol 1968;73:556-8.
91. Woolfolk RL, McNulty TF. Relaxation treatment for insomnia: a component analysis. J Consult Clin Psychol 1983;51:495-503.
92. Lacks P, Bertelson AD, Gans L, Kunkel J. The effectiveness of three behavioral treatments for different degrees of sleep onset insomnia. Behavior Therapy 1983;14:593-605.
93. Cannici J, Malcolm R, Peek LA. Treatment of insomnia in cancer patients using muscle relaxation training. J Behav Ther Exp Psychiatry 1983;14:251-6.
94. Demiralp M, Oflaz F, Komurcu S. Effects of relaxation training on sleep quality and fatigue in patients with breast cancer undergoing adjuvant chemotherapy. J Clin Nurs 2010;19:1073-83.
95. Adamsen L, Stage M, Laursen J, Rørth M, Quist M. Exercise and relaxation intervention for patients with advanced lung cancer: a qualitative feasibility study. Scand J Med Sci Sports 2012;22:804-15.
96. Ritterband LM, Bailey ET, Thorndike FP, Lord HR, Farrell-Carnahan L, Baum LD. Initial evaluation of an Internet intervention to improve the sleep of cancer survivors with insomnia. Psychooncology 2012;21:695-705.
97. Zhou ES, Vrooman LM, Manley PE, Crabtree VM, Recklitis CJ. Adapted delivery of cognitive-behavioral treatment for insomnia in adolescent and young adult cancer survivors: a pilot study. Behav Sleep Med 2017;15:288-301.
98. Morin CM, LeBlanc M, Daley M, Gregoire JP, Mérette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med 2006;7:123-30.
99. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
100. Davidson JR, Waisberg JL, Brundage MD, MacLean AW. Nonpharmacologic group treatment of insomnia: a preliminary study with cancer survivors. Psychooncology 2001;10:389-97.
101. Quesnel C, Savard J, Simard S, Ivers H, Morin CM. Efficacy of cognitive-behavioral therapy for insomnia in women treated for nonmetastatic breast cancer. J Consult Clin Psychol 2003;71:189-200.
102. Epstein DR, Dirksen SR. Randomized trial of a cognitive-behavioral intervention for insomnia in breast cancer survivors. Oncol Nurs Forum 2007;34:E51-9.
103. Dirksen SR, Epstein DR. Efficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors. J Adv Nurs 2008;61:664-75.
105. Garland SN, Carlson LE, Antle MC, Samuels C, Campbell T. I-CAN SLEEP: rationale and design of a non-inferiority RCT of mindfulnessbased stress reduction and cognitive behavioral therapy for the treatment of insomnia in CANcer survivors. Contemp Clin Trials 2011;32:747-54.
106. Fleming L, Randell K, Harvey CJ, Espie CA. Does cognitive behaviour therapy for insomnia reduce clinical levels of fatigue, anxiety and depression in cancer patients? Psychooncology 2014;23:679-84.
107. Matthews EE, Berger AM, Schmiege SJ, Cook PF, McCarthy MS, Moore CM, et al. Cognitive behavioral therapy for insomnia outcomes in women after primary breast cancer treatment: a randomized, controlled trial. Oncol Nurs Forum 2014;41:241-53.
108. Garland SN, Rouleau CR, Campbell T, Samuels C, Carlson LE. The comparative impact of mindfulness-based cancer recovery (MBCR) and cognitive behavior therapy for insomnia (CBT-I) on sleep and mindfulness in cancer patients. Explore (NY) 2015;11:445-54.
109. Casault L, Savard J, Ivers H, Savard MH. A randomized-controlled trial of an early minimal cognitive-behavioural therapy for insomnia comorbid with cancer. Behav Res Ther 2015;67:45-54.
110. Roscoe JA, Garland SN, Heckler CE, Perlis ML, Peoples AR, Shayne M, et al. Randomized placebo-controlled trial of cognitive behavioral therapy and armodafinil for insomnia after cancer treatment. J Clin Oncol 2015;33:165-71.
111. Garland SN, Gehrman P, Barg FK, Xie SX, Mao JJ. CHoosing Options for Insomnia in Cancer Effectively (CHOICE): design of a patient centered comparative effectiveness trial of acupuncture and cognitive behavior therapy for insomnia. Contemp Clin Trials 2016;47:349-55.
112. Heckler CE, Garland SN, Peoples AR, Perlis ML, Shayne M, Morrow GR, et al. Cognitive behavioral therapy for insomnia, but not armodafinil, improves fatigue in cancer survivors with insomnia: a randomized placebo-controlled trial. Support Care Cancer 2016;24:2059-66.
113. Kamen C, Garland SN, Heckler CE, Peoples AR, Kleckner IR, Cole CL, et al. Social support, insomnia, and adherence to cognitive behavioral therapy for insomnia after cancer treatment. Behav Sleep Med 2017;1-3.
115. Chung S, Youn S. The optimizing strategies for prescription of sleeping pills for insomnia patients. Sleep Med Res 2017;8:8-16.